Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XLO compared with LKFT: revenue, margins and what each company keeps, and the suppliers and customers both name
XLO
Xilio Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LKFT
Lakefront Biotherapeutics NV
Change
Mkt cap
Revenue
Revenue
vs
Compare
XLO
Xilio Therapeutics, Inc.
vs
LKFT
Lakefront Biotherapeutics NV
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
XLO
Xilio Therapeutics, Inc.
Change
7.97
▼
−0.75%
· post 7.97
Mkt cap
$155.0M
Revenue
$19M
Q2 FY26
Revenue
$44M
FY25
LKFT
Lakefront Biotherapeutics NV
Change
32.08
▼
−0.61%
· post 32.08
Closed
Nov 2 '26
Mkt cap
$2.1B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 2 '26
XLO
Xilio Therapeutics, Inc.
vs
LKFT
Lakefront Biotherapeutics NV
7.97
▼
−0.75%
post 7.97
Price
32.08
▼
−0.61%
post 32.08
$155.0M
Mkt cap
$2.1B
Q2 FY26
$19M
Revenue
—
FY25
$44M
Revenue
—
Change
Change
XLO
7.97
▼
−0.75%
vs
LKFT
32.08
▼
−0.61%
Closed
Nov 2 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
XLO: latest quarter is a loss; flow not drawable. LKFT: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
XLO, solid
LKFT, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only XLO
0
None
Shared
0
No disclosed counterparties: XLO.
Only LKFT
2
GILD
Gilead Sciences
customer
—
Alfasigma
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR